Iko1996 if you're reading this, I think it's safe to say your prior concerns about no run up into earnings should be put to rest.
Breaking news: Time Magazine decided the Ebola fighters deserve this recognition. I agree....Don't think for a minute that just because you don't hear about any US cases of Ebola, the disease went away. Nothing can be further from the truth. The battle rages on in Africa and other nations. And I'm betting what we hear from the company in after hours today will confirm the huge demand for their products.
The one thing no one has mentioned in this thread is the fact that a fund decided to take a percentage holding interest in LAKE, in other words, they purchased over 300,000 shares. For a stock with this small float,
that's a huge investment and commitment/belief in the future of this company. My feeling is hospitals around the globe will become proactive and keep adequate inventories of protective equipment, to be ready for any outbreak of disease in the future, not just Ebola. So don't worry about a stock run up into earnings, there's too much of an unknown here; i.e. the street really doesn't know how to value LAKE just yet, but trust me they will after tomorrow evening.
Actually it's amazing it hasn't sold off at all in AH....Frankly, I wouldn't be surprised if CELG does a full acquisition......In case you're wondering highflier, yes I'm #$%$ because I bought AGIO months ago at about $40, and sold at $45 with a profit, and no, I never bought it back!! UGH....
You could see this coming. The stock is up over 400% on the year, and the drugs are in Phase I trials....What, and you thought management and others wouldn't take a profit? Think again. I'm buying back in the mid $90's.
Everyone is getting out. The big selling started 6 days ago. Maybe there's some support at about $107.
Oh no, shorts are holding it down again in pre-market. It's all about those shorts, 'bout those shorts, no
Where Apple goes, the market and technology will go. It's about time, isn't it? Maybe now the market will fall back to 1900 or so. As for Apple? Apparently no one cares about I-pads, too much competition.
You're delusional. Shorts don't hold a stock down, sellers do. This stock is up almost 400%....and you think shorts are "holding it down?" What the hell are you smoking?
This is Yahoo finance; the internet. The SEC let's Jim Cramer yell and scream and tell people what to buy and what not to buy, and he interviews CEO's on his show; and the SEC lets CNBC guests pump stocks all day long, and the SEC turns the other way when analysts downgrade a stock (like they did with AGIO), so that their clients can get in before the news.......And you think the SEC would waste their time looking at a post on Yahoo Finance? The guy asked an honest question.....Just because you interpret that as trying to deceive people doesn't mean that's his agenda.......
And by the way.....the prognosis for the patients in these trials is not death....
I get the efficacy and the positive reports......I understand the partnership with Celgene......The drug is very promising......What I don't get is why the stock is basically parabolic....It's gone from about $78 to $114 in two weeks....2 weeks! Everyone knew about these results, it was clearly priced in. This was a Phase I report.....Now you need backing and filling and consolidation, before the stock can move up again.
That means a move to around $95 or so.
This news over the weekend was positive, but it was expected by the market. The FDA rushing a drug through trials is without precedent, and extremely rare. This was about a Phase I trial. A consolidation, and backing and filling move to around $80 or so is expected. Traders expectations need to be reset on this stock, because it's been parabolic for awhile.
Simply put, I'm expecting sell the news here. No, I'm not short, and I'd never short a biotech, it's suicide. But I would consider going long in the low $80's. It's possible the stock could gap up Monday morning, but I'd
expect that move to be faded. How can you not take a profit from $30 to $110?
Weak numbers, longer time for Fed to raise rates. Good numbers, Fed still in the game because of low inflation. Just ask CNBC, they know everything.
Retail hires for the upcoming weak Xmas season. It's all spin.
I'd rather the stock moves up in small increments, instead of just the usual large candle short squeeze, where many traders just jump out. There's now a 300,000 share floor in the stock, and with a float this small, I don't have to tell you that one news release could drive this much higher....That said, I much prefer the smaller stock moves.
Roubini has been WRONG in every one of his calls the past 5 years. There's no reason to think he's right now.